… The therapeutic promise of multipotent mesenchymal stem/stromal cells (MSC), a population
of adult stem cells that can differentiate into cells deriving from mesoderm lineage, is rising […

… to generate proadipogenic cell delivery platforms. The adipogenic differentiation of human
mesenchymal stromal cells (hMSCs) in vitro is commonly induced by treating the cells with …

… Gene-modified mesenchymal stromal cells (MSC) provide a promising tool for cell and
gene therapy-based applications by potentially acting as a cellular vehicle for protein-…

… We further provide potential pitfalls of the MSC-OV platform and the strategies under … strategy
for the delivery of cancer therapeutic agents is the use of mesenchymal stromal cells (MSCs…

… has been considered as the first choice cell delivery platform for diabetic wound healing.
Mouse bone marrow-derived MSCs (BM-MSCs) and AD-MSCs delivered with a type I rat tail …

… cells. This work demonstrates the potential utility of mesenchymal stem-cell-based chemotherapy
drug delivery … The large-scale production of mesenchymal stromal cells (MSCs) loaded …

… to home to tumor site and serve as a delivery platform for chemotherapeutic agents. … stromal
cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Stem Cells …

… types with tumor-homing ability can be developed as drug delivery vehicles … -homing cells,
mesenchymal stem/stromal cells (MSCs) are the most attractive candidates for drug delivery …

… Mesenchymal stromal cells (MSCs), also known as mesenchymal stem cells, have been
intensely investigated … (4) Utilize the MSCs secretome as a drug delivery platform for treatment …

… stromal cells, besides, the current status on the targeting drugs as well as the drug delivery
… tumour stromal cells, the antitumor drugs targeting stromal cells and the DDS are discussed. …